Press Release | February 24, 2022
Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Read More
Press Release | February 3, 2022
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
Read More
News | January 28, 2022
Cyrus Biotechnology CEO Lucas Nivon featured in Fierce Biotech Webinar
Read More
News | January 25, 2022
Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform
Read More
